Advertisement

Medical Microbiology and Immunology

, Volume 203, Issue 4, pp 251–256 | Cite as

Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative Staphylococcal infections in a subset of extremely low birth weight neonates

  • Roland Abou Jaoude
  • Adel Zauk
  • Charlotte Morel
  • Diane McClure
  • Michael Lamacchia
  • Vincent A. DeBari
Original Investigation

Abstract

Fluconazole prophylaxis is being used efficaciously in the neonatal intensive care unit (NICU) for fungal prophylaxis in very low birth weight and extremely low birth weight (ELBW) neonates. Little is known about the effect of fluconazole prophylaxis on bacterial infections. The purpose of this study was to examine that issue in a subset of ELBW, those weighing ≤900 g at birth. This is a retrospective study conducted in a level III NICU at state-designated children hospital in New Jersey (USA). We examined the data from our records of neonates ≤900 g birth weight during the period March 1, 2007–February 28, 2011. Inclusion in the study was all infants ≤900 g before (n = 67) and after (n = 81) the institution of fluconazole prophylaxis. Fluconazole prophylaxis was accompanied by a significant decrease in both the rate and number of days of bacterial infections as well as co-infections. We found that the incidence of coagulase-negative Staphylococcus (CONS) decreased from 46.2 to 24.7 % (OR 2.63; 95 % CI 1.31–5.27). Similarly, days of infection also decreased significantly (p < 0.0001). These data suggest that fluconazole prophylaxis may be associated with a reduction in CONS infections in that subset of ELBW neonates.

Keywords

Fluconazole Coagulase negative Staphylococcus Neonatal intensive care unit Extremely low birth weight Neonates Infection rates 

Notes

Acknowledgments

We would like to thank Dr. Helen Kest for her support and encouragement during the course of this study. Portions of this work were presented at the Association of Clinical Scientists 132nd meeting, Mobile, AL, 23-27 May, 2012. Abstract: Ann. Clin Lab Sci 2012; 42: 223.

References

  1. 1.
    Weitkamp JH, Ozdas A, Lafleur B, Potts AL (2008) Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J Perinatol 28:405–411PubMedCrossRefGoogle Scholar
  2. 2.
    Manzoni P, Leonessa ML, Galetto P, Latino MA, Arisio R, Maule M et al (2008) Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select fluconazole-resistant candida subspecies. Pediatr Infect Dis J 27:731–737PubMedCrossRefGoogle Scholar
  3. 3.
    Kaufman D, Boyle R, Hazen K, Patrie J, Robinson M, Donowitz LG (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345:1660–1666PubMedCrossRefGoogle Scholar
  4. 4.
    Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G et al (2007) A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356(24):2483–2495PubMedCrossRefGoogle Scholar
  5. 5.
    Usukura Y, Igarashi T (2003) Examination of severe, hospital acquired infections affecting extremely low birth weight infants. Pediatr Int 45:230–232PubMedCrossRefGoogle Scholar
  6. 6.
    Peleg A, Hogan DA, Mylonakis E (2010) Medically important bacterial–fungal interactions nature reviews. Microbiology 8:340–349PubMedGoogle Scholar
  7. 7.
    Kobayashi DY, Crouch JA (2009) Bacterial/fungal interactions: from pathogens to mutualistic endosymbionts. Annu Rev Phytopathol 47:63–82PubMedCrossRefGoogle Scholar
  8. 8.
    Venkatesh MP, Don P, Fein M, Kong L, Weisman LE (2007) Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth. Antimicrob Agents Chemother 51(4):1240–1245PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposure over time and the risk of Clostridium difficile infection. Clin Infect Dis 53:42–48PubMedCrossRefGoogle Scholar
  10. 10.
    Horn SD, Schumacher DN (1982) Comparing classification methods: measurements of variations in charges, length of stay and mortality. Med Care 20:489–500PubMedCrossRefGoogle Scholar
  11. 11.
    Adam B, Baillie GS, Douglas LJ (2002) Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 51:344–349PubMedGoogle Scholar
  12. 12.
    Bradford R, Abdul Manan R, Garland SM, Daley AJ, Deighton MA (2011) Coagulase-negative staphylococci in low birth weight infants: environmental factors affecting biofilm production in Staphylococcus epidermidis. Curr Microbiol 62(3):850–854PubMedCrossRefGoogle Scholar
  13. 13.
    Azoulay E, Timsit JF, Tafflet M, De Lassence A, Darmon M, Zahar JR et al (2006) Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 129:110–117PubMedCrossRefGoogle Scholar
  14. 14.
    O’Sullivan JM, Jenkinson HF, Cannon RD (2000) Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology 146:41–48PubMedGoogle Scholar
  15. 15.
    Spear GT, Zariffard MR, Cohen MH, Sha BE (2008) Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol 78:76–79PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Gale D, Sandoval B (1957) Response of mice to the inoculations of both Candida albicans and Escherichia coli I: the enhancement phenomenon. J Bacteriol 73:616–624PubMedCentralPubMedGoogle Scholar
  17. 17.
    Carlson E, Johnson G (1985) Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice. Infect Immun 50:655–659PubMedCentralPubMedGoogle Scholar
  18. 18.
    Carlson E (1983) Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. Infect Immun 39:193–197PubMedCentralPubMedGoogle Scholar
  19. 19.
    Carlson E (1983) Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality. Infect Immun 42:285–292PubMedCentralPubMedGoogle Scholar
  20. 20.
    McGuire W, Clerihew L (2010) The effect of fluconazole prophylaxis in very low birthweight infants is overestimated by before–after studies. Arch Dis Child Fetal Neonatal Ed 95:182–187CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Roland Abou Jaoude
    • 1
  • Adel Zauk
    • 1
    • 2
  • Charlotte Morel
    • 2
  • Diane McClure
    • 1
  • Michael Lamacchia
    • 1
    • 2
  • Vincent A. DeBari
    • 2
    • 3
  1. 1.Department of Pediatrics, St. Joseph’s Children’s HospitalMount Sinai School of MedicinePatersonUSA
  2. 2.New York Medical CollegeValhallaUSA
  3. 3.Department of Medicine, School of Health and Medical SciencesSeton Hall UniversitySouth OrangeUSA

Personalised recommendations